This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Feline T-cell Surface Glycoprotein CD8 Alpha Chain (CD8A)
Product Overview
BioVenic's Recombinant Feline T-cell Surface Glycoprotein CD8 Alpha Chain (CD8A) is a recombinant protein expressed from E.coli. Its predicted molecular weight is 26.1 kDa. The purity is>85% (SDS-PAGE).
Specifications
Target Information
Feline T-cell Surface Glycoprotein CD8 Alpha Chain (CD8A) is a key immune molecule on cytotoxic T lymphocytes. It acts as a co-receptor with the T cell receptor (TCR) to bind MHC class I molecules, enhancing target cell recognition and killing. CD8A also plays a crucial role in T cell development and activation by recruiting LCK kinase. It helps maintain immune homeostasis and has potential applications in cancer immunotherapy.
Shipping and Storage
This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.